Title of article
Assessing the Effectiveness of Botulinum Toxin Injections for Adductor Spasmodic Dysphonia: Clinician and Patient Perception
Author/Authors
Maia N. Braden، نويسنده , , Michael M. Johns III، نويسنده , , Adam M. Klein، نويسنده , , John M. Delgaudio، نويسنده , , Marina Gilman، نويسنده , , Edie R. Hapner، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2010
Pages
8
From page
242
To page
249
Abstract
To determine the effectiveness of Botox treatment for adductor spasmodic dysphonia (ADSD), the clinician and patient judge changes in voice symptoms and the effect on quality of life. Currently, there is no standard protocol for determining the effectiveness of Botox injections in treating ADSD. Therefore, clinicians use a variety of perceptual scales and patient-based self-assessments to determine patientsʹ impressions of severity and changes after treatments. The purpose of this study was to assess clinician-patient agreement of the effects of Botox on voice quality and quality of life in ADSD. Retrospective chart review of 199 randomly selected patients since 2004. Results indicated a weak correlation between the patientʹs assessment of voice impairment (EIS) and patientʹs quality of life impairment (Voice-Related Quality of Life [V-RQOL]) in the mild-moderate dysphonia severity group and the moderate-to-severe dysphonia group. There was a weak correlation between the patientʹs assessment of voice impairment EIS and the clinicianʹs perceptual judgment of voice impairment (Consensus Auditory Perceptual Evaluation of Voice [CAPE-V]) only in the moderate to severe dysphonia group. There was a weak correlation between the patientʹs quality of life impairment (V-RQOL) and the clinicianʹs perceptual judgment of voice impairment (CAPE-V) only in the severe to profound dysphonia group. The poor relationship among commonly used outcome measures leads us to question how best to assess the effectiveness of Botox in ADSD. Clinicians are required to document treatment outcomes, making it important to use scales that are valid, reliable, and sensitive to change. Future research directions include examining relationships between measures both before and after Botox injections, examining the specific factors that determine quality of life changes, and further research on specific parameters of the CAPE-V as well as comparing perceptual and quality of life scales with acoustic and aerodynamic measures in this population would be beneficial in the move toward more effective ways of measuring change.
Keywords
ADSD , Botulinum Toxin , treatment effectiveness , Perceptual voice assessment
Journal title
Journal of Voice
Serial Year
2010
Journal title
Journal of Voice
Record number
1280582
Link To Document